(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally...
Stats | |
---|---|
本日の出来高 | 642.00 |
平均出来高 | 8 930.00 |
時価総額 | 14.80M |
EPS | $0 ( 2024-03-21 ) |
次の収益日 | ( $0 ) 2024-05-07 |
Last Dividend | $0.0700 ( 2023-05-24 ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.54 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-22 | Mehalik Daniella | Buy | 70 000 | Stock Option (Right to Buy) |
2024-01-22 | Mehalik Daniella | Buy | 35 000 | Stock Option (Right to Buy) |
2023-11-27 | Mehalik Daniella | Sell | 0 | Common Stock, $.005 Par Value |
2023-09-21 | Shoemaker Shannon | Buy | 80 000 | Stock Option (Right to Buy) |
2023-09-21 | Shoemaker Shannon | Buy | 40 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
94.08 |
Last 96 transactions |
Buy: 1 000 549 | Sell: 33 710 |
Psychemedics Corp 相関
10 最も負の相関 | |
---|---|
CLDX | -0.902 |
BNIXU | -0.901 |
BLZE | -0.881 |
NUTX | -0.878 |
RDVT | -0.872 |
GLMD | -0.844 |
STIM | -0.843 |
BGNE | -0.843 |
COFS | -0.842 |
HALO | -0.842 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Psychemedics Corp 財務諸表
Annual | 2023 |
収益: | $22.10M |
総利益: | $8.41M (38.07 %) |
EPS: | $-0.720 |
FY | 2023 |
収益: | $22.10M |
総利益: | $8.41M (38.07 %) |
EPS: | $-0.720 |
FY | 2022 |
収益: | $25.24M |
総利益: | $9.29M (36.81 %) |
EPS: | $-0.190 |
FY | 2021 |
収益: | $24.91M |
総利益: | $10.26M (41.21 %) |
EPS: | $-0.119 |
Financial Reports:
No articles found.
Psychemedics Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0800 | 1997-01-13 |
Last Dividend | $0.0700 | 2023-05-24 |
Next Dividend | $0 | N/A |
Payout Date | 2023-06-08 | |
Next Payout Date | N/A | |
# dividends | 100 | -- |
Total Paid Out | $12.60 | -- |
Avg. Dividend % Per Year | 1.61% | -- |
Score | 2.88 | -- |
Div. Sustainability Score | 2.34 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0.792 | -- |
Year | Amount | Yield |
---|---|---|
1997 | $0.400 | 1.67% |
1998 | $0.440 | 1.87% |
1999 | $0.640 | 3.20% |
2000 | $0.640 | 3.56% |
2001 | $0.400 | 2.00% |
2002 | $0.240 | 1.46% |
2003 | $0.320 | 3.43% |
2004 | $0.320 | 3.37% |
2005 | $0.360 | 2.82% |
2006 | $0.475 | 3.39% |
2007 | $0.575 | 2.99% |
2008 | $0.660 | 4.13% |
2009 | $0.580 | 9.01% |
2010 | $0.480 | 6.08% |
2011 | $0.480 | 5.66% |
2012 | $0.600 | 6.49% |
2013 | $0.600 | 5.52% |
2014 | $0.600 | 4.14% |
2015 | $0.600 | 3.98% |
2016 | $0.600 | 6.17% |
2017 | $0.600 | 2.50% |
2018 | $0.690 | 3.33% |
2019 | $0.720 | 4.46% |
2020 | $0.180 | 2.00% |
2021 | $0.0500 | 0.97% |
2022 | $0.210 | 2.94% |
2023 | $0.140 | 2.84% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.188 | 1.500 | -3.76 | -5.64 | [0 - 0.5] |
returnOnAssetsTTM | -0.313 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.498 | 1.500 | -6.64 | -9.96 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.445 | 0.800 | 7.77 | 6.22 | [1 - 3] |
quickRatioTTM | 1.204 | 0.800 | 7.62 | 6.10 | [0.8 - 2.5] |
cashRatioTTM | 0.417 | 1.500 | 8.79 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.173 | -1.500 | 7.11 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 4.22 | 1.000 | 9.55 | 9.55 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.255 | 2.00 | -0.0850 | -0.170 | [0 - 30] |
freeCashFlowPerShareTTM | -0.277 | 2.00 | -0.138 | -0.277 | [0 - 20] |
debtEquityRatioTTM | 0.344 | -1.500 | 8.62 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.381 | 1.000 | 6.99 | 6.99 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.132 | 1.000 | -4.64 | -4.64 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.644 | 1.000 | -4.69 | -4.69 | [0.2 - 2] |
assetTurnoverTTM | 1.665 | 0.800 | 2.23 | 1.785 | [0.5 - 2] |
Total Score | 2.34 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -3.56 | 1.000 | -0.461 | 0 | [1 - 100] |
returnOnEquityTTM | -0.498 | 2.50 | -4.27 | -9.96 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.277 | 2.00 | -0.0923 | -0.277 | [0 - 30] |
dividendYielPercentageTTM | 2.75 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.255 | 2.00 | -0.0850 | -0.170 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.239 | 1.500 | -1.741 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0670 | 1.000 | -4.17 | 0 | [0.1 - 0.5] |
Total Score | -0.760 |
Psychemedics Corp
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine and Fentanyl. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。